These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31405600)

  • 1. Systematic review of oral and craniofacial findings in patients with Fabry disease or Pompe disease.
    Benz K; Hahn P; Hanisch M; Lücke K; Lücke T; Jackowski J
    Br J Oral Maxillofac Surg; 2019 Nov; 57(9):831-838. PubMed ID: 31405600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders.
    Kuech EM; Brogden G; Naim HY
    Biochimie; 2016 Nov; 130():152-162. PubMed ID: 27664461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac involvement in Lysosomal Storage Diseases.
    Sestito S; Parisi F; Tallarico V; Tarsitano F; Roppa K; Pensabene L; Chimenz R; Ceravolo G; Calabrò MP; De Sarro R; Moricca MT; Bonapace G; Concolino D
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):107-119. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in Taiwan.
    Liao HC; Chiang CC; Niu DM; Wang CH; Kao SM; Tsai FJ; Huang YH; Liu HC; Huang CK; Gao HJ; Yang CF; Chan MJ; Lin WD; Chen YJ
    Clin Chim Acta; 2014 Apr; 431():80-6. PubMed ID: 24513544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal storage disorders: Novel and frequent pathogenic variants in a large cohort of Indian patients of Pompe, Fabry, Gaucher and Hurler disease.
    Thomas DC; Sharma S; Puri RD; Verma IC; Verma J
    Clin Biochem; 2021 Mar; 89():14-37. PubMed ID: 33301762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatable lysosomal storage diseases in the advent of disease-specific therapy.
    Peters H; Ellaway C; Nicholls K; Reardon K; Szer J
    Intern Med J; 2020 Nov; 50 Suppl 4():5-27. PubMed ID: 33210402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease.
    Lukas J; Knospe AM; Seemann S; Citro V; Cubellis MV; Rolfs A
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for lysosomal storage disorders.
    Nakamura K; Hattori K; Endo F
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):63-71. PubMed ID: 21312327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzyme replacement therapy for lysosomal storage disorders].
    Valayannopoulos V; Brassier A; Chabli A; Caillaud C; Lemoine M; Odent T; Arnoux JB; de Lonlay P
    Arch Pediatr; 2011 Oct; 18(10):1119-23. PubMed ID: 21873040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
    Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
    Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.
    Chen X; Qiu W; Ye J; Han L; Gu X; Zhang H
    J Hum Genet; 2016 Apr; 61(4):345-9. PubMed ID: 26740238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified newborn screening protocol for lysosomal storage disorders.
    Metz TF; Mechtler TP; Orsini JJ; Martin M; Shushan B; Herman JL; Ratschmann R; Item CB; Streubel B; Herkner KR; Kasper DC
    Clin Chem; 2011 Sep; 57(9):1286-94. PubMed ID: 21771947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn Screening for Lysosomal Storage Disorders.
    Anderson S
    J Pediatr Health Care; 2018; 32(3):285-294. PubMed ID: 29678259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme reconstitution/replacement therapy for lysosomal storage diseases.
    Burrow TA; Hopkin RJ; Leslie ND; Tinkle BT; Grabowski GA
    Curr Opin Pediatr; 2007 Dec; 19(6):628-35. PubMed ID: 18025928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspectives on newborn screening for later-onset lysosomal storage diseases.
    Lisi EC; Gillespie S; Laney D; Ali N
    Mol Genet Metab; 2016 Sep; 119(1-2):109-14. PubMed ID: 27591925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal storage disorders affecting the heart: a review.
    Nair V; Belanger EC; Veinot JP
    Cardiovasc Pathol; 2019; 39():12-24. PubMed ID: 30594732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children.
    Galeotti A; De Rosa S; Uomo R; Dionisi-Vici C; Deodato F; Taurisano R; Olivieri G; Festa P
    Orphanet J Rare Dis; 2020 Nov; 15(1):329. PubMed ID: 33228748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.